ENLV
Enlivex Ltd.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K/A | 10/2/2026 | View on SEC |
| 6-K/A | 10/1/2026 | View on SEC |
| 6-K | 9/29/2026 | View on SEC |
| 6-K | 9/25/2026 | View on SEC |
| 6-K | 9/22/2026 | View on SEC |
| 424B3 | 8/17/2026 | View on SEC |
| EFFECT | 8/13/2026 | View on SEC |
| SCHEDULE 13G | 8/13/2026 | View on SEC |
| 6-K | 8/11/2026 | View on SEC |
| F-3 | 8/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ENLV |
| Company Name | Enlivex Ltd. |
| CIK | 1596812 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | L3 |
| Phone | 972 (0) 3 7326616 |